Court approves convening of scheme meeting
Filed with ASX · · 4 pages · English
Summary by 6ix AI
Mayne Pharma Group Ltd. has announced that the Supreme Court of New South Wales has approved the convening of a meeting for shareholders to vote on a proposed scheme of arrangement with Cosette Pharmaceuticals. The Independent Expert has concluded that the scheme is fair and in the best interests of Mayne Pharma shareholders, and the directors recommend voting in favor of it. The Scheme Meeting is scheduled to take place as a hybrid meeting, allowing shareholders to participate both in person and online. The Scheme Booklet, which contains detailed information about the scheme, will be distributed to shareholders following its registration with the Australian Securities and Investments Commission.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Mayne Pharma Group Ltd. on 6ix
Story so far
Earlier from Mayne Pharma
- Response to ASX Price Query
- Pause in Trade
- Response to ASX Query
- Sol-Gel and Mayne Pharma Announce the Purchase of EPSOLAY® and TWYNEO® in the U.S.
- 2025 Half Year Investor Presentation
Later from Mayne Pharma
- ASIC registration of Mayne Pharma scheme booklet
- Update on Scheme with Cosette
- Response to ASX Aware Letter
- Update on Scheme of Arrangement with Cosette
- Mayne Pharma receives purported notice to terminate SID
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma